Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like FDA Lashes Out at Jazz Pharma CMO for Continued Regulatory Violations January 26, 2017 Orphan Therapeutics, LLC Applauds For Trailblazer Lifetime Achievement Award September 19, 2017 Teva Expected to Fire Up to 1,700 Workers in Israel, U.S. November 26, 2017
